SCHEMBL14720786

SCHEMBL14720786

O=S(=O)(Cc1ccc(C=C2CCN(C3CCC3)CC2)cc1)NC1CCOCC1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
SRD5A2 P31213 2/20 0.37
HRH3 Q9Y5N1 8/20 0.35
KCNH2 Q12809 1/20 0.35
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
F2R P25116 1/20 0.32
AXL P30530 1/20 0.31
ALDH1A1 P00352 2/20 0.31
L3MBTL3 Q96JM7 1/20 0.31
MAPT P10636 1/20 0.31
MLNR O43193 1/20 0.31
HPGD P15428 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720731 0.84 ALDH1A1 (0.45) HRH3KCNH2ALDH1A1MAPTHPGD
SCHEMBL14721402 0.82 MAPT (0.44) SRD5A2HRH3ALDH1A1L3MBTL3MAPT
SCHEMBL14722546 0.80 USP2 (0.45) SRD5A2HRH3HPGD
SCHEMBL14720817 0.76 SRD5A2 (0.43) SRD5A2HRH3ALDH1A1LMNA
SCHEMBL14721060 0.76 KCNH2 (0.43) SRD5A2HRH3KCNH2ALDH1A1HPGD
SCHEMBL14720486 0.76 NAMPT (0.38) SRD5A2HRH3ALDH1A1HPGD
SCHEMBL14720710 0.75 HRH3 (0.56) HRH3L3MBTL3
SCHEMBL14721508 0.75 HRH3 (0.38) SRD5A2HRH3L3MBTL3
SCHEMBL14731157 0.74 SRD5A2 (0.37) SRD5A2HRH3ALDH1A1L3MBTL3HPGD
SCHEMBL14720887 0.73 POLB (0.52) ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed